Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability.
Angew Chem Int Ed Engl. 2024 Mar 22;63(13):e202318515. doi: 10.1002/anie.202318515. Epub 2024 Feb 23.
Angew Chem Int Ed Engl. 2024.
PMID: 38320193
Insufficient accumulation of lipid nanoparticles (LNPs)-based mRNA vaccines in antigen presenting cells remains a key barrier to eliciting potent antitumor immune responses. Herein, we develop dendritic cells (DCs) targeting LNPs by taking advantage of mannose receptor-med …
Insufficient accumulation of lipid nanoparticles (LNPs)-based mRNA vaccines in antigen presenting cells remains a key barrier to elic …
Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy.
Qi S, Zhang X, Yu X, Jin L, Yang K, Wang Y, Feng Y, Lei J, Mao Z, Yu G.
Qi S, et al.
Adv Mater. 2024 Jun;36(23):e2311574. doi: 10.1002/adma.202311574. Epub 2024 Mar 8.
Adv Mater. 2024.
PMID: 38433564
Item in Clipboard
Cite
Cite